Oppenheimer Maintains Outperform Rating on Wave Life Sciences, Sets $29 Target
Oppenheimer maintained its Outperform rating on Wave Life Sciences and set a $29 price target. The note cited a 740.6% implied upside from the Oct. 27 close of $3.45.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.